+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Non-invasive Prenatal Testing Market by Component, Test Method, Gestation Period, Application, End-User - Global Forecast to 2030- Product Image
Non-invasive Prenatal Testing Market by Component, Test Method, Gestation Period, Application, End-User - Global Forecast to 2030- Product Image
Sale

Non-invasive Prenatal Testing Market by Component, Test Method, Gestation Period, Application, End-User - Global Forecast to 2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968595
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Non-invasive prenatal testing (NIPT) is rapidly establishing itself as a standard in prenatal screening due to its minimally invasive approach and ability to provide valuable early insights into fetal health. As healthcare systems prioritize both efficiency and patient safety, stakeholders across the healthcare spectrum are increasingly integrating NIPT to optimize outcomes and streamline diagnostic pathways.

Market Snapshot: Non-Invasive Prenatal Testing Market

The Non-Invasive Prenatal Testing Market grew from USD 7.51 billion in 2024 to USD 8.30 billion in 2025. It is expected to continue growing at a CAGR of 10.74%, reaching USD 13.86 billion by 2030. This upward market trajectory is driven by innovation in genetic analysis, regulatory evolution, and the broader adoption of advanced screening options across diverse healthcare environments. The market’s steady growth reflects robust clinical demand, enhanced payer recognition, and continuing technological progress in prenatal diagnostics.

Scope & Segmentation

This report delivers a detailed analysis of trends, opportunities, and dynamics shaping the non-invasive prenatal testing space. Coverage is organized as follows:

  • Component: Consumables and reagents, instruments such as microarrays, next-generation sequencing systems, polymerase chain reaction devices, and ultrasound equipment.
  • Test Method: Biochemical screening, cell-free DNA assays in maternal plasma, and ultrasound detection techniques.
  • Gestation Period: Testing windows include 10-17 weeks, 18-23 weeks, and above 23 weeks, aligning with key clinical decision points.
  • Application Areas: Early detection of microdeletion syndromes, sex chromosomal abnormalities, and trisomies 21, 18, and 13.
  • End-User Segments: Diagnostic laboratories, hospitals, and specialty clinics, each with distinctive operational requirements and adoption patterns.
  • Regional Coverage: Markets across the Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (multiple countries), and Asia-Pacific (including China, India, Japan, Australia, and others).
  • Key Companies: Profiling over 20 leading organizations including Agilent Technologies, Illumina, Natera, PerkinElmer, Quest Diagnostics, and others.

Key Takeaways: Strategic Insights for Decision-Makers

  • Major advancements in next-generation sequencing have significantly enhanced the accuracy and reach of NIPT, allowing for earlier and more comprehensive screening options.
  • Collaborative partnerships between test developers, sequencing platform providers, and clinical laboratories are shaping supply chain efficiency and broadening market access.
  • Segment-specific needs, such as high-throughput demand in centralized labs versus rapid turnaround in clinical settings, are driving portfolio diversification and solution refinement across end-users.
  • Regional deployment strategies remain critical; markets mature at different rates based on regulatory environment, reimbursement models, and healthcare infrastructure.
  • The competitive landscape is marked by both global leaders delivering high-throughput platforms and regional entrants offering localized panels tailored to specific population genetics.
  • Greater payer acceptance and supporting clinical guidelines continue to drive broader adoption, especially where early detection yields measurable clinical and operational advantages.

Tariff Impact: US Market Adjustments and Global Supply Chains

The introduction of new US tariffs in 2025 has altered procurement strategies for key instrumentation and reagents, driving laboratories and manufacturers to adopt more flexible sourcing and localization approaches. Stakeholders are mitigating increased costs by leveraging domestic production, renegotiating supplier terms, and optimizing distribution logistics. Although these adjustments present operational challenges, clinical demand and favourable reimbursement environments offset short-term disruptions, maintaining steady growth trajectories for NIPT adoption.

Methodology & Data Sources

Our research combines in-depth interviews with clinical leaders and laboratory directors alongside the latest peer-reviewed literature, regulatory records, and company financials. All data points are cross-validated with independent sector experts to ensure relevance and reliability.

Why This Report Matters

  • Actionable intelligence for aligning investments with emerging NIPT technologies, evolving regional requirements, and shifting reimbursement frameworks.
  • Clarity on competitive positioning for both established and new market entrants, enabling informed decisions about strategic partnerships, expansion, and product development.
  • Comprehensive overview supporting optimal resource allocation and risk mitigation in a fluctuating global regulatory and economic landscape.

Conclusion

Non-invasive prenatal testing continues to reshape modern prenatal care. This report equips senior decision-makers with the clarity to navigate evolving trends, segment-specific requirements, and global market dynamics for strategic success.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Non-invasive Prenatal Testing Market, by Component
8.1. Introduction
8.2. Consumables & Reagents
8.3. Instruments
8.3.1. Microarrays
8.3.2. Next-Generation Sequencing Systems
8.3.3. Polymerase Chain Reaction Instruments
8.3.4. Ultrasound Devices
9. Non-invasive Prenatal Testing Market, by Test Method
9.1. Introduction
9.2. Biochemical Screening Tests
9.3. Cell-free DNA in Maternal Plasma Tests
9.4. Ultrasound Detection
10. Non-invasive Prenatal Testing Market, by Gestation Period
10.1. Introduction
10.2. 10-17 Week
10.3. 18-23 Week
10.4. Above 23 Week
11. Non-invasive Prenatal Testing Market, by Application
11.1. Introduction
11.2. Microdeletion Syndrome
11.3. Sex Chromosomal Abnormalities
11.4. Trisomy
12. Non-invasive Prenatal Testing Market, by End-User
12.1. Introduction
12.2. Diagnostic Laboratories
12.3. Hospitals
12.4. Specialty Clinics
13. Americas Non-invasive Prenatal Testing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Non-invasive Prenatal Testing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Non-invasive Prenatal Testing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Agilent Technologies, Inc.
16.3.2. Berry Genomics Co. Ltd.
16.3.3. BGI Group
16.3.4. BillionToOne, Inc.
16.3.5. Biora Therapeutics, Inc.
16.3.6. BioReference Laboratories, Inc.
16.3.7. Centogene N.V.
16.3.8. Eurofins Scientific (Ireland) Limited
16.3.9. F.Hoffmann-La Roche Ltd.
16.3.10. GE HealthCare Technologies Inc.
16.3.11. Igenomix S.L.U
16.3.12. Illumina, Inc.
16.3.13. Laboratory Corporation of America Holdings
16.3.14. Lilac Insights Pvt. Ltd.
16.3.15. MedGenome Labs Ltd.
16.3.16. Myriad Genetics, Inc.
16.3.17. Natera, Inc.
16.3.18. PerkinElmer Inc.
16.3.19. Quest Diagnostics Incorporated
16.3.20. Ravgen Inc.
16.3.21. Sonic Healthcare USA
16.3.22. Thermo Fisher Scientific Inc.
16.3.23. Yourgene Health by Novacyt UK Holdings Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. NON-INVASIVE PRENATAL TESTING MARKET MULTI-CURRENCY
FIGURE 2. NON-INVASIVE PRENATAL TESTING MARKET MULTI-LANGUAGE
FIGURE 3. NON-INVASIVE PRENATAL TESTING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. NON-INVASIVE PRENATAL TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. NON-INVASIVE PRENATAL TESTING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. NON-INVASIVE PRENATAL TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BIOCHEMICAL SCREENING TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CELL-FREE DNA IN MATERNAL PLASMA TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ULTRASOUND DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY 10-17 WEEK, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY 18-23 WEEK, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ABOVE 23 WEEK, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SEX CHROMOSOMAL ABNORMALITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TRISOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 44. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 45. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 46. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 47. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 48. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 51. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 52. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 53. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 54. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 75. UNITED KINGDOM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 76. UNITED KINGDOM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 77. UNITED KINGDOM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 78. UNITED KINGDOM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 79. UNITED KINGDOM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. UNITED KINGDOM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 82. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 83. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 84. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 85. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 88. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 89. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 90. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 91. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 94. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 95. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 96. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 97. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 100. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 101. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 102. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 103. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 106. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 107. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 108. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 109. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 112. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 113. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 114. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 115. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 130. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 131. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 132. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 133. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 142. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 143. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 144. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 145. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 148. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 149. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 150. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 151. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 153. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 154. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 155. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 156. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 157. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 160. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 161. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 162. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 163. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 166. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 167. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 168. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 169. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 172. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 173. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 174. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 175. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 177. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 178. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 179. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 180. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 181. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 184. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 185. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 186. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 187. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 190. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 191. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 192. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 193. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 196. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 197. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 198. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 199. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 208. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 209. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 210. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 211. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 212. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 214. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 215. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 216. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 217. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 218. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 220. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 221. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 222. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 223. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 224. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 232. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 233. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 234. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 235. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 236. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 238. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 239. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 241. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 242. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 244. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 245. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 246. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 247. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 248. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 250. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 251. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 252. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 253. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 254. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 256. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 259. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 260. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 262. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 263. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 264. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 265. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 266. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 268. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 269. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 270. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 271. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 272. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 274. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 275. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
TABLE 277. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2030 (USD MILLION)
TABLE 278. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 280. NON-INVASIVE PRENATAL TESTING MARKET SHARE, BY KEY PLAYER, 2024
TABLE 281. NON-INVASIVE PRENATAL TESTING MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Non-invasive Prenatal Testing market report include:
  • Agilent Technologies, Inc.
  • Berry Genomics Co. Ltd.
  • BGI Group
  • BillionToOne, Inc.
  • Biora Therapeutics, Inc.
  • BioReference Laboratories, Inc.
  • Centogene N.V.
  • Eurofins Scientific (Ireland) Limited
  • F.Hoffmann-La Roche Ltd.
  • GE HealthCare Technologies Inc.
  • Igenomix S.L.U
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings
  • Lilac Insights Pvt. Ltd.
  • MedGenome Labs Ltd.
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • PerkinElmer Inc.
  • Quest Diagnostics Incorporated
  • Ravgen Inc.
  • Sonic Healthcare USA
  • Thermo Fisher Scientific Inc.
  • Yourgene Health by Novacyt UK Holdings Limited

Table Information

Report AttributeDetails
No. of Pages181
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 8.3 Billion
Forecasted Market Value ( USD ) by 2030 $ 13.86 Billion
Compound Annual Growth Rate10.7%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Non-Invasive Prenatal Testing (NIPT) - Global Strategic Business Report - Product Image

Non-Invasive Prenatal Testing (NIPT) - Global Strategic Business Report

  • Report
  • 456 Pages
  • Global
From
Non-invasive Prenatal Testing Market Report 2025 - Product Image

Non-invasive Prenatal Testing Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Non-invasive Prenatal Testing (NIPT) Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Non-invasive Prenatal Testing (NIPT) Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 183 Pages
  • Global
From
Prenatal Diagnostics - Global Strategic Business Report - Product Image

Prenatal Diagnostics - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Non-Invasive Prenatal Testing (NIPT) Market by Product & Service (Consumables (Assay Kits & Reagents), Instruments (NGS Systems, Microarrays)), Method (Biochemical Screening, Cell-Free DNA Test), End User (Diagnostic Labs) - Global Forecast to 2029 - Product Image

Non-Invasive Prenatal Testing (NIPT) Market by Product & Service (Consumables (Assay Kits & Reagents), Instruments (NGS Systems, Microarrays)), Method (Biochemical Screening, Cell-Free DNA Test), End User (Diagnostic Labs) - Global Forecast to 2029

  • Report
  • 371 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.